The results of this seroprevalence analysis showed a positivity rate among individuals assisted by the internal healthcare system of the Vatican City State lower than that found in other studies on similar samples. This may be due to the small sample size and to the low number of COVID-19 cases tracked in the Vatican City State thanks to the control and prevention measures taken by the Directorate of Health and Hygiene. These measures were applied uninterruptedly through the first and second waves and included preventive measures such as hand disinfection, social distancing, use of face masks, body temperature measurement and symptom screening, as well as clinical surveillance, isolation protocols for symptomatic individuals and careful evaluation of all potential contacts.

SARS-CoV-2 seroprevalence in the Vatican city state / Ralli, M.; Arcangeli, A.; Soave, P. M.; Voglino, M. C.; De-Giorgio, F.. - In: EUROPEAN JOURNAL OF INTERNAL MEDICINE. - ISSN 0953-6205. - (2021). [10.1016/j.ejim.2021.01.029]

SARS-CoV-2 seroprevalence in the Vatican city state

Ralli M.
Primo
;
2021

Abstract

The results of this seroprevalence analysis showed a positivity rate among individuals assisted by the internal healthcare system of the Vatican City State lower than that found in other studies on similar samples. This may be due to the small sample size and to the low number of COVID-19 cases tracked in the Vatican City State thanks to the control and prevention measures taken by the Directorate of Health and Hygiene. These measures were applied uninterruptedly through the first and second waves and included preventive measures such as hand disinfection, social distancing, use of face masks, body temperature measurement and symptom screening, as well as clinical surveillance, isolation protocols for symptomatic individuals and careful evaluation of all potential contacts.
2021
COVID-19; SARS-CoV-2; seroprevalence; Vatican city state
01 Pubblicazione su rivista::01f Lettera, Nota
SARS-CoV-2 seroprevalence in the Vatican city state / Ralli, M.; Arcangeli, A.; Soave, P. M.; Voglino, M. C.; De-Giorgio, F.. - In: EUROPEAN JOURNAL OF INTERNAL MEDICINE. - ISSN 0953-6205. - (2021). [10.1016/j.ejim.2021.01.029]
File allegati a questo prodotto
File Dimensione Formato  
Ralli_SARS-CoV-2 seroprevalence_2021.pdf

accesso aperto

Note: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859713/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 461.69 kB
Formato Adobe PDF
461.69 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1512391
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact